Fig. 2.

Adjusted results in triptan insufficient responders (TIRs) and triptan sufficient responders (TSRs) (response based on efficacy): health-related quality of life: (a) MSQ scores and (b) EQ-5D-5L scores; and (c) disability: MIDAS scores. Data were controlled for age, sex, migraine headache day frequency, comorbidities, preventive medication use, and with or without aura. Higher scores on MIDAS indicate greater disability; higher scores on MSQ and EQ-5D-5L indicate better quality of life and health state, respectively. *p = 0.009, ^†0.015, ^‡0.043, ^§0.002, ** < 0.001 for TSRs versus TIRs. CI confidence interval, EQ-5D EuroQol 5-dimension questionnaire, EQ-5D-5L EuroQol 5-dimension 5-level questionnaire, LS least squares, MIDAS Migraine Disability Assessment, MSQ Migraine-Specific Quality of Life questionnaire, VAS visual analog scale